Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease

This publication has 14 references indexed in Scilit:

• In Vivo Clearance of an Intracellular Bacterium,Francisella tularensisLVS, Is Dependent on the p40 Subunit of Interleukin-12 (IL-12) but Not on IL-12 p70
  Infection and Immunity, 2002
• Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis
  Vaccine, 2001
• Purified Lipopolysaccharide fromFrancisella tularensisLive Vaccine Strain (LVS) Induces Protective Immunity against LVS Infection That Requires B Cells and Gamma Interferon
  Infection and Immunity, 2000
• Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism
  FEMS Immunology & Medical Microbiology, 1996
• Francisella tularensis: Host-parasite interaction
  FEMS Immunology & Medical Microbiology, 1996
• Increased encapsulation and virulence of Francisella tularensis live vaccine strain (LVS) by subculturing on synthetic medium
  Vaccine, 1994
• Passive Protection of Mice Against Lethal Francisella Tularensis (Live Tularemia Vaccine Strain) Infection by the Sera of Human Recipients of the Live Tularemia Vaccine
  The Lancet Healthy Longevity, 1994
• The tularaemia vaccine
  Journal of Chemical Technology & Biotechnology, 1994
• Introduction of Francisella tularensis at skin sites induces resistance to infection and generation of protective immunity
  Microbial Pathogenesis, 1992
• Studies on the Immunogenic Properties of Bacterium Tularense Variants
  The Journal of Infectious Diseases, 1952